The global antiretroviral therapy market is anticipated to reach US$35.14 billion in 2024. The market is predicted to experience growth at a CAGR of 3.40% during the period spanning 2020-2024.

The growth in the antiretroviral therapy market is supported by various factors including rising prevalence of HIV, growing access to antiretroviral therapy, increasing intake of PrEP and surging prevalence of mother-to-child transmission of HIV.

Request for Sample Report: https://www.sdki.jp/sample-request-58830

"The Final Report will cover the impact analysis of COVID-19 on this industry (Global Antiretroviral Therapy Market)."

The global antiretroviral therapy market by drug type can be segmented into the following: NRTI, NNRTI, protease inhibitors and integrase inhibitors.

The dominant share of the market in 2019 was held by NRTI, followed by NNRTI, protease inhibitors and integrase inhibitors.

In 2019, the dominant share of the market was held by North America, followed by Europe and Asia Pacific.

North America is predicted to dominate the global antiretroviral therapy market, supported by various factors like increasing funds on research & development activity and surging number of coronavirus infected cases.

Request for Sample Report: https://www.sdki.jp/sample-request-58830

"The Final Report will cover the impact analysis of COVID-19 on this industry (Global Antiretroviral Therapy Market)."

Scope of the report:
The report provides a comprehensive analysis of the global antiretroviral therapy market with potential impact of COVID-19.
The major regional markets (North America, Europe and APAC) have been analyzed.
The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
The competitive landscape of the market, along with the company profiles of leading players (Gilead Sciences, GSK, Roche Holding, Boehringer Ingelheim, Cipla and Abbvie) are also presented in detail.
Key Target Audience:
Antiretroviral Therapy Providers
Hospitals/Clinics
Healthcare Companies
End Users (Businesses/Consumers)
Investment Banks
Government Bodies & Regulating Authorities

+ Table of Content

1. Market Overview
1.1 Antiretroviral Therapy
1.2 Types of Antiretroviral Drugs
1.3 Side Effects of HIV Drugs
2. Impact of COVID-19
2.1 Global Impact of COVID-19
2.2 Change in Organic Traffic
2.3 Rising Prevalence of COVID-19
2.4 Impact on Healthcare Spending
3. Market Analysis
3.1 Global Antiretroviral Therapy Market by Value
3.2 Global Antiretroviral Therapy Market Forecast by Value
3.3 Global Antiretroviral Therapy Market by Drug Type
3.3.1 Global NRTI Antiretroviral Therapy Market by Value
3.3.2 Global NRTI Antiretroviral Therapy Market Forecast by Value
3.3.3 Global NNRTI Antiretroviral Therapy Market by Value
3.3.4 Global NNRTI Antiretroviral Therapy Market Forecast by Value
3.3.5 Global Protease Inhibitors Antiretroviral Therapy Market by Value
3.3.6 Global Protease Inhibitors Antiretroviral Therapy Market Forecast by Value
3.3.7 Global Integrase Inhibitors Antiretroviral Therapy Market by Value
3.3.8 Global Integrase Inhibitors Antiretroviral Therapy Market Forecast by Value
3.3.9 Global Other Drug Antiretroviral Therapy Market by Value
3.3.10 Global Other Drug Antiretroviral Therapy Market Forecast by Value


For more market news and updates click here : https://sdki-blogs-market-news.blogspot.com